GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (CAI:IDHC.CA) » Definitions » Cyclically Adjusted PS Ratio

Integrated Diagnostics Holdings (CAI:IDHC.CA) Cyclically Adjusted PS Ratio : (As of Jun. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Integrated Diagnostics Holdings Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Integrated Diagnostics Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Integrated Diagnostics Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Cyclically Adjusted PS Ratio Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.09 2.38 1.28 1.58

Integrated Diagnostics Holdings Quarterly Data
Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.28 - - 1.58

Competitive Comparison of Integrated Diagnostics Holdings's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Cyclically Adjusted PS Ratio falls into.


;
;

Integrated Diagnostics Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Integrated Diagnostics Holdings's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Integrated Diagnostics Holdings's adjusted Revenue per Share data for the fiscal year that ended in Dec24 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=9.533/133.1571*133.1571
=9.533

Current CPI (Dec24) = 133.1571.

Integrated Diagnostics Holdings Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201512 1.691 99.792 2.256
201612 1.951 101.863 2.550
201712 2.524 104.011 3.231
201812 3.202 105.998 4.022
201912 3.711 108.420 4.558
202012 4.427 109.897 5.364
202112 8.708 117.630 9.857
202212 6.008 125.222 6.389
202312 6.871 129.419 7.069
202412 9.533 133.157 9.533

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Integrated Diagnostics Holdings  (CAI:IDHC.CA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Integrated Diagnostics Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings Headlines

No Headlines